Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jul;106(3):610–615. doi: 10.1111/j.1476-5381.1992.tb14383.x

P2y purinoceptor responses of beta cells and vascular bed are preserved in diabetic rat pancreas.

D Hillaire-Buys 1, R Gross 1, J Chapal 1, G Ribes 1, M M Loubatières-Mariani 1
PMCID: PMC1907575  PMID: 1504744

Abstract

1. To investigate the effect of experimental diabetes on the P2y purinoceptor responses of pancreatic beta-cells and vascular bed, we used adenosine-5'-O-(2-thiodiphosphate) (ADP beta S), a potent and stable P2y agonist. This work was performed in the isolated perfused pancreas of the rat. 2. Diabetes was induced by streptozotocin (66 mg kg-1, i.p.). Five weeks after the induction of diabetes, on the day of pancreas isolation, the animals displayed marked hyperglycaemia (37.6 +/- 2.7 mM). Age-matched rats were used as controls. 3. Insulin response to a glucose stimulation from 5 to 10 mM was completely lost and stimulation of insulin release by the sulphonylurea, tolbutamide (185 microM), was drastically impaired in the diabetic pancreas (maximum responses were 1.5 +/- 0.4 and 7.0 +/- 1.4 ng min-1 for diabetic and age-matched rats respectively). 4. In contrast, in the diabetic pancreas ADP beta S (15 microM), infused in the presence of glucose 5 mM, elicited an immediate and significant insulin release similar to that observed in the age-matched pancreas (maximum responses were 7.6 +/- 1.5 and 6.7 +/- 1.3 ng min-1 respectively). This ADP beta S stimulating effect occurred independently of the glucose concentration (5, 8.3 and 28 mM) in the diabetic pancreas. On pancreatic vascular resistance, ADP beta S induced a similar vasodilatation in diabetic and age-matched rats. 5. In conclusion, ADP beta S retains its insulin stimulatory and vasodilator effects in experimental diabetes; P2y purinoceptors could therefore be considered as a new target for the development of antidiabetic drugs.

Full text

PDF
610

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alric R., Mariani M. M., Loubatières A. Importance de l'état des éléments figurés du sang et en particulier de celui des globules rouges sur les valeurs du glucose sanguin mesurées par l'auto-analyseur Technicon. Pathol Biol. 1965 May;13(9):506–511. [PubMed] [Google Scholar]
  2. Bertrand G., Chapal J., Loubatières-Mariani M. M., Roye M. Evidence for two different P2-purinoceptors on beta cell and pancreatic vascular bed. Br J Pharmacol. 1987 Aug;91(4):783–787. doi: 10.1111/j.1476-5381.1987.tb11276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertrand G., Chapal J., Puech R., Loubatières-Mariani M. M. Adenosine-5'-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas. Br J Pharmacol. 1991 Mar;102(3):627–630. doi: 10.1111/j.1476-5381.1991.tb12223.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  5. Cohen M. L., Berkowitz B. A. Age-related changes in vascular responsiveness to cyclic nucleotides and contractile agonists. J Pharmacol Exp Ther. 1974 Oct;191(1):147–155. [PubMed] [Google Scholar]
  6. Giroix M. H., Portha B., Kergoat M., Bailbe D., Picon L. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas. Diabetes. 1983 May;32(5):445–451. doi: 10.2337/diab.32.5.445. [DOI] [PubMed] [Google Scholar]
  7. Gordon J. L. Extracellular ATP: effects, sources and fate. Biochem J. 1986 Jan 15;233(2):309–319. doi: 10.1042/bj2330309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grill V., Herberg L. Glucose- and arginine-induced insulin and glucagon responses from the isolated perfused pancreas of the BB-Wistar diabetic rat. Evidence for selective impairment of glucose regulation. Acta Endocrinol (Copenh) 1983 Apr;102(4):561–566. doi: 10.1530/acta.0.1020561. [DOI] [PubMed] [Google Scholar]
  9. Gross R., Hillaire-Buys D., Bertrand G., Ribes G., Loubatieres-Mariani M. M. Diabetes and impaired response of glucagon cells and vascular bed to adenosine in rat pancreas. Diabetes. 1989 Oct;38(10):1291–1295. doi: 10.2337/diab.38.10.1291. [DOI] [PubMed] [Google Scholar]
  10. Gross R., Hillaire-Buys D., Ribes G., Loubatières-Mariani M. M. Diabetes alters the responses of glucagon secreting cells and vascular bed to isoprenaline and forskolin in vitro in rat pancreas. Life Sci. 1991;48(24):2349–2358. doi: 10.1016/0024-3205(91)90272-d. [DOI] [PubMed] [Google Scholar]
  11. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  12. Hillaire-Buys D., Chapal J., Petit P., Loubatières-Mariani M. M. Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes. Eur J Pharmacol. 1991 Jul 9;199(3):309–314. doi: 10.1016/0014-2999(91)90494-b. [DOI] [PubMed] [Google Scholar]
  13. Kamata K., Miyata N., Kasuya Y. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol. 1989 Jun;97(2):614–618. doi: 10.1111/j.1476-5381.1989.tb11993.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kamata K., Miyata N., Kasuya Y. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther. 1989 Jun;249(3):890–894. [PubMed] [Google Scholar]
  15. Lacy P. E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967 Jan;16(1):35–39. doi: 10.2337/diab.16.1.35. [DOI] [PubMed] [Google Scholar]
  16. Leahy J. L., Bonner-Weir S., Weir G. C. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes. 1984 Jul;33(7):667–673. doi: 10.2337/diab.33.7.667. [DOI] [PubMed] [Google Scholar]
  17. Loubatieres-Mariani M. M., Chapal J. Purinergic receptors involved in the stimulation of insulin and glucagon secretion. Diabete Metab. 1988 Mar-Apr;14(2):119–126. [PubMed] [Google Scholar]
  18. Loubatières A., Mariani M. M., Ribes G., de Malbosc H., Chapal J. Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. Diabetologia. 1969 Feb;5(1):1–10. doi: 10.1007/BF01212212. [DOI] [PubMed] [Google Scholar]
  19. Marliss E. B., Nakhooda A. F., Poussier P., Sima A. A. The diabetic syndrome of the 'BB' Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia. 1982 Apr;22(4):225–232. doi: 10.1007/BF00281296. [DOI] [PubMed] [Google Scholar]
  20. Mulhern M., Docherty J. R. Effects of experimental diabetes on the responsiveness of rat aorta. Br J Pharmacol. 1989 Aug;97(4):1007–1012. doi: 10.1111/j.1476-5381.1989.tb12555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Okabayashi Y., Otsuki M., Ohki A., Tani S., Baba S. Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats. Diabetes. 1989 Aug;38(8):1042–1047. doi: 10.2337/diab.38.8.1042. [DOI] [PubMed] [Google Scholar]
  22. Serradas P., Bailbé D., Portha B. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin. Diabetologia. 1989 Aug;32(8):577–584. doi: 10.1007/BF00285331. [DOI] [PubMed] [Google Scholar]
  23. Unger R. H., Aguilar-Parada E., Müller W. A., Eisentraut A. M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest. 1970 Apr;49(4):837–848. doi: 10.1172/JCI106297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weir G. C., Clore E. T., Zmachinski C. J., Bonner-Weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes. 1981 Jul;30(7):590–595. doi: 10.2337/diab.30.7.590. [DOI] [PubMed] [Google Scholar]
  25. White T. D. Role of adenine compounds in autonomic neurotransmission. Pharmacol Ther. 1988;38(2):129–168. doi: 10.1016/0163-7258(88)90095-2. [DOI] [PubMed] [Google Scholar]
  26. Wood B. E., Squire A., O'Connor S. E., Leff P. ADP-beta-F is not a selective P2y-receptor agonist in rabbit jugular vein. Br J Pharmacol. 1989 Dec;98 (Suppl):794P–794P. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES